• OPEN AN ACCOUNT
Indian Indices
Nifty
25,355.25 -120.85
(-0.47%)
Sensex
82,500.47 -689.81
( -0.83%)
Bank Nifty
56,956.00 -257.55
( -0.45%)
Nifty IT
38,376.65 -304.20
( -0.79%)
Global Indices
Nasdaq
44,666.69 187.38
(0.42%)
Dow Jones
6,300.60 16.34
(0.26%)
Hang Seng
39,553.98 -92.38
(-0.23%)
Nikkei 225
8,975.66 108.64
(1.23%)
Forex
USD-INR
85.73 0.00
(0.00%)
EUR-INR
100.42 -0.13
(-0.13%)
GBP-INR
116.48 -0.10
(-0.08%)
JPY-INR
0.58 0.00
(-0.13%)

EQUITY - MARKET SCREENER

Samor Reality Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
543376
INE0GD201014
27.0707965
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
148.01
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

bosch ltd
Lupin launches Ipratropium Bromide Nasal Solution in US market
Jul 04,2025

Lupin announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% are bioequivalent to Atrovent® Nasal Spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals, Inc.

Ipratropium Bromide Nasal Solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children aged 6 years and older. Ipratropium Bromide Nasal Solution (Nasal Spray) 0.06% is indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children aged 5 years and older.

Ipratropium Bromide Nasal Solution (RLD Atrovent®) had estimated annual sales of USD 63 million in the U.S. (IQVIA MAT May 2025).